Consolidation Chemotherapy Provided Survival Benefit for Esophageal Squamous Cell Carcinoma Patients Who Underwent Concurrent Chemoradiotherapy Lower Than <scp>60 Gy</scp>
We recommend that CCT treatment should be considered for ESCC patients who underwent CCRT using < 60 Gy. Further studies are needed to confirm these results.
Authors
- HuaLei Zhang
- Ping Wang (ORCID: https://orcid.org/0000-0001-7259-9284)
- Bo Tang (ORCID: https://orcid.org/0000-0002-8712-7025)
- Qi Wang (ORCID: https://orcid.org/0000-0001-6243-1402)
Institutions
- Hebei Medical University (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Zhengzhou University (CN)
- Fourth Hospital of Hebei Medical University (CN)
- Henan Cancer Hospital (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1111/1759-7714.70012
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00